ACLX vs CLOV
Arcellx Inc (ACLX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ACLX currently screens at market cap $6.73B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ACLX and CLOV stock pages for the full models.
Not investment advice.